Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Pfizer appoints Dr Yvonne Greenstreet to specialty care business

February 3, 2011 Research and Development Dr Yvonne Greenstreet, Pfizer, appointment, specialty care

Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …
Appointment
Roche Severin Schwann

Roche weathers tough year and looks to pipeline for 2011

February 3, 2011 Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab

Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
News

Blood clot fears halt cancer trial enrolment

February 3, 2011 Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer

Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …
News
Sandwich R&D

Government seeks to salvage Pfizer site

February 2, 2011 Research and Development Pfizer, Sandwich

Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …
News

Leading universities sound alarm over UK research

February 2, 2011 Research and Development Jobs, Pfizer, Sandwich, universities

Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …
News
Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011 Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
News

UK hails high uptake of cervical cancer vaccine

January 31, 2011 Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
News

GSK and Actelion drop insomnia treatment

January 30, 2011 Research and Development Actelion, GSK, insomnia

Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …
News

EMA road map to prioritise pharmacovigilance

January 28, 2011 Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance

The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
News

Bertil Lindmark joins Almirall as R&D head

January 27, 2011 Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Appointment

Lilly Oncology chief resigns

January 27, 2011 Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
News

The Evolving Role of European Regulatory Agencies

January 26, 2011 Research and Development Consultancy, regulatory affairs, regulatory agencies

The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …
Feature
Thought Leadership

Pharma-biotech partnerships: creative approaches to doing the deal

January 26, 2011 Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering

Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …
Feature

Sanofi buys into cancer antibody research

January 26, 2011 Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research

Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
News

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011 Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026